Phosphorus binders : trigger for intestinal diverticula formation in an ADPKD patient

Copyright by Società Italiana di Nefrologia SIN, Rome, Italy..

Hyperphosphoremia is common in patients with chronic kidney disease and is an important risk factor in this patient population. Phosphate binding drugs are a key therapeutic strategy to reduce phosphoremia levels, although they have significant side effects especially in the gastrointestinal tract, such as gastritis, diarrhoea and constipation. We report the case of a haemodialysis-dependent patient suffering from chronic kidney disease stage V KDIGO secondary to polycystic autosomal dominant disease; treated with phosphate binders, the case was complicated by the appearance of diverticulosis, evolved into acute diverticulitis.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 38(2021), 2 vom: 14. Apr.

Sprache:

Italienisch

Beteiligte Personen:

Garozzo, Maurizio [VerfasserIn]
Gullè, Concetta Luisa Monica [VerfasserIn]
Clementi, Anna [VerfasserIn]
Milone, Filippo [VerfasserIn]
Battaglia, Giovanni Giorgio [VerfasserIn]

Themen:

27YLU75U4W
Acute diverticulitis
Case Reports
Chronic kidney disease
Diverticulosis
Hyperphosphoremia
Letter
Phosphate binding drugs
Phosphorus
Polycystic autosomal dominant disease

Anmerkungen:

Date Completed 25.10.2021

Date Revised 25.10.2021

published: Electronic

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32407042X